tradingkey.logo

Tandem Diabetes Care Inc

TNDM
查看詳細走勢圖
21.700USD
-0.800-3.56%
收盤 01/09, 16:00美東報價延遲15分鐘
1.47B總市值
虧損本益比TTM

Tandem Diabetes Care Inc

21.700
-0.800-3.56%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-3.56%

5天

+0.70%

1月

+1.17%

6月

+34.20%

今年開始到現在

-1.27%

1年

-39.72%

查看詳細走勢圖

TradingKey Tandem Diabetes Care Inc股票評分

單位: USD 更新時間: 2026-01-09

操作建議

Tandem Diabetes Care Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名80/208位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為23.09。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Tandem Diabetes Care Inc評分

相關信息

行業排名
80 / 208
全市場排名
188 / 4562
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Tandem Diabetes Care Inc亮點

亮點風險
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
業績高增長
公司營業收入穩步增長,連續3年增長17.35%
估值合理
公司最新PE估值-7.16,處於3年歷史合理位
機構減倉
最新機構持股79.08M股,環比減少22.08%
景順投資公司持倉
明星投資者景順投資公司持倉,最新持倉250.16K股
活躍度增加
近期活躍度增加,過去20天平均換手率0.67

分析師目標

基於 24 分析師
買入
評級
23.091
目標均價
-0.26%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Tandem Diabetes Care Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Tandem Diabetes Care Inc簡介

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
公司代碼TNDM
公司Tandem Diabetes Care Inc
CEOSheridan (John F)
網址https://www.tandemdiabetes.com/

常見問題

Tandem Diabetes Care Inc(TNDM)的當前股價是多少?

Tandem Diabetes Care Inc(TNDM)的當前股價是 21.700。

Tandem Diabetes Care Inc 的股票代碼是什麼?

Tandem Diabetes Care Inc的股票代碼是TNDM。

Tandem Diabetes Care Inc股票的52週最高點是多少?

Tandem Diabetes Care Inc股票的52週最高點是37.930。

Tandem Diabetes Care Inc股票的52週最低點是多少?

Tandem Diabetes Care Inc股票的52週最低點是9.980。

Tandem Diabetes Care Inc的市值是多少?

Tandem Diabetes Care Inc的市值是1.47B。

Tandem Diabetes Care Inc的淨利潤是多少?

Tandem Diabetes Care Inc的淨利潤為-96.03M。

現在Tandem Diabetes Care Inc(TNDM)的股票是買入、持有還是賣出?

根據分析師評級,Tandem Diabetes Care Inc(TNDM)的總體評級為買入,目標價格為23.091。

Tandem Diabetes Care Inc(TNDM)股票的每股收益(EPS TTM)是多少

Tandem Diabetes Care Inc(TNDM)股票的每股收益(EPS TTM)是-3.030。
KeyAI